Home > News > featured news > Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

MEDICAL DEVICES

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

Medtronic | January 11, 2022

Medtronic plc, a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of the Micra™ AV Transcatheter Pacing System (TPS), and the company will launch the product this month.

This approval expands the number of patients in Japan – one of the largest markets in the world – who are eligible to receive the Micra TPS, the world's smallest pacemaker. The Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical signals between the chambers of the heart (the atria and the ventricle) are impaired. The Micra TPS is the first-ever leadless pacemaker; its first version (the Micra VR) was approved in Japan in 2017 for patients who only require single-chamber pacing.

"Pacemakers have made significant progress over their approximately 60-year history, including miniaturization, improvements in pacing technology, MRI compatibility, and remote monitoring," explained Kyoko Soejima, professor of cardiovascular internal medicine at Kyorin University Hospital and a member of the Micra TPS Global Clinical Trial steering committee. "The first Micra system transformed the concept of pacemakers by eliminating surgical pockets and leads, and Micra AV promises to deliver the benefits of leadless pacing to a larger number of patients because ventricular pacing can be performed synchronously with the atrium."

Historically, patients with AV block have been treated with traditional dual-chamber pacemakers which are implanted in the upper chest, under the skin below the collar bone, and connected to the heart using thin wires called "leads." Identical in size and shape to the original Micra TPS, Micra AV has several additional algorithms which detect cardiac movement, allowing the device to adjust pacing in the ventricle to coordinate with the atrium, providing "AV synchronous" pacing therapy to patients with AV block.

The Micra AV approval is based on data from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study, which evaluated the safety and effectiveness of accelerometer-based atrial sensing algorithms. The study evaluated the ability of the Micra's internal sensor to monitor and detect atrial contractions and enable coordinated pacing between the atrium and ventricle, thereby providing AV synchrony.

"Since introducing the first battery-powered external pacemaker in 1957 to the innovative Micra leadless pacemaker portfolio, Medtronic continues to pioneer pacing innovations for physicians and their patients."

Rob Kowal, M.D., Ph.D., chief medical officer of the Cardiac Rhythm Management business at Medtronic

About the Micra Transcatheter Pacing Systems (TPS)
The Micra TPS received CE Mark in April 2015 and U.S. FDA approval in 2016. Comparable in size to a large vitamin, Micra is less than one-tenth the size of traditional pacemakers yet delivers advanced pacing technology to patients via a minimally invasive approach. During the implant procedure, the device is attached to the heart with small tines and delivers electrical impulses that pace the heart through an electrode at the end of the device.

Unlike traditional pacemakers, Micra does not require leads or a surgical "pocket" under the skin, so potential sources of complications related to leads and pockets are reduced, and there is no visible sign of the device.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

Spotlight

Effective digital marketing strategies for healthcare providers

Are you struggling to reach patients online? Increase your online visibility & attract more patients with effective healthcare marketing strategies from BraveLabs.

More featured news

Spotlight

Effective digital marketing strategies for healthcare providers

Are you struggling to reach patients online? Increase your online visibility & attract more patients with effective healthcare marketing strategies from BraveLabs.

Related News

HEALTH TECHNOLOGY, MEDICAL DEVICES

Validic integrates with Smart Meter cellular-enabled connected health devices

prnewswire | March 28, 2023

Validic Inc., a market-leading digital health and personalized care company, continues to expand its healthcare IoT platform with the integration of Smart Meter. This integration brings exclusive cellular-enabled, patient-friendly monitoring devices supplied by Smart Meter, a leading connected health solution supplier to a rapidly growing nationwide network of SmartPartners, to the Validic ecosystem. Smart Meter's proprietary, cellular, FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G private data network to ensure an engaging patient experience for improved adherence. The devices help manage the most prevalent chronic conditions, including blood glucose monitors for diabetes; blood pressure monitors for hypertension and other cardiac diseases; pulse oximeters for COPD, COVID-19, and other respiratory disorders; and weight scales for congestive heart failure and weight-related diseases. "Our proprietary monitoring devices can only connect and transmit patient-generated data when connected to our private data network, ensuring reliable and secure delivery to Validic clients," said Smart Meter Chief Marketing Officer Bill Bassett. "And eliminating the need for patients to pair, sync or connect to Wi-Fi or an app on their phone may improve patient satisfaction and increase the use of their monitoring devices." Validic's health IoT platform is the largest ecosystem of connected health devices and apps, which streams continuous, near-real-time personal health data from 540+ home health and wearable devices. Organizations can access blood pressure, pulse oxygen, blood glucose, heart rate, weight, temperature, sleep, nutrition, respiratory, activity data, and more through a single, endpoint connection. "Technology should be so easy to use that it becomes invisible to the person using it," said Validic CEO Drew Schiller. "The addition of Smart Meter cellular-enabled health monitoring devices to our ecosystem offers another option to help people focus on their health and live their best lives." About Validic Founded in 2010, Validic Inc. is a digital health and personalized care company devoted to our mission of improving the quality of human life by making personal data actionable. With the world's largest health IoT platform and EHR-embedded remote care application, we help healthcare organizations give every person tailored interventions and personalized care, improving healthcare efficiency and delivery, and empowering people to play an active role in their health and well-being. Leading healthcare providers, health plans and health IT companies, such as Mass General Brigham, Cleveland Clinic, Mayo Clinic, CVS Health and Elevance Health, use our solutions to deliver high-touch and personalized chronic condition management, remote care, and support for healthy living. With a platform intentionally built to support a broad digital health strategy and scale across populations and conditions, Validic supports the largest RPM program in the country, with more than 300,000 enrolled patients since its inception and 7,000 referring providers. Our digital health platform has 540+ supported devices with more than 15 billion annual data transactions. Our remote care solution is available as a standard integration in the Epic Connection Hub and Cerner Millennium®. In 2022, Validic received the North American Customer Value Award for the Medical Device Connectivity Industry by Frost and Sullivan and was named Best Overall Connected Healthcare Solution by MedTech Breakthrough. Validic is HIPAA-compliant, HITRUST CSF Certified®, and ISO-27001 certified for Information Security Management.

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

REVIV Partners with Randox Health

Businesswire | April 24, 2023

SVP for Retail Health, Joanne Lomas-Braithwaite, is pleased to announce the partnership between REVIV Global and Randox Health. Randox Health was established in 1982 and is the largest healthcare diagnostics company in the UK and Ireland. For over 40 years Randox have been focusing on the provision of timely and accurate proteomic and genomic testing to identify risk to health and promote preventative healthcare. With personalised, private health packages designed to provide real-time insights on current health and future health risks, Randox Health’s nationwide network of clinics offer unique access to health data to help monitor and improve your health. The exciting partnership is a first for Randox who will be offering REVIV’s therapies in their clinics alongside their own diagnostic testing. REVIV’s full menu of IV drip therapies and IM booster shots will be available for their customers to support their journey to optimize their wellness. On REVIV partnering with Randox, David Ferguson, Chief Operating Officer, says: “Over the past few years, we've seen a dramatic change in people's behaviours as they seek to understand their health and wellbeing better. At Randox Health, we provide a range of specialised health packages that enable you to take control of your health. “Our innovative diagnostic technologies can deliver hundreds of results to give you a comprehensive overview of your health and help detect the earliest signs of illness. Collaborating with REVIV is a natural next step, combining our world-class diagnostic services with REVIV signature IV therapies to help our customers protect their current and future health.” Joanne Lomas-Braithwaite, SVP Retail Health, says: “We are thrilled about the future of our multi-unit Express partnership with Randox, a prominent figure in healthcare diagnostic testing. Through our new digital SaaS solution, Express, this collaboration will extend our goal of providing personalised nutrition experiences to our customers, with an increased accessibility to our customers through Randox's extensive clinic network.” About REVIV REVIV is a global leader in doctor-led preventative health services. Education sits at the very core of REVIV. We continually strive to raise awareness on the importance of preventative health and provide the public with the resources to be able to take control of their health. We were founded in 2010 by four doctors who experienced long, emotionally challenging hours in the emergency room. These experiences led them to the decision that the public needed to become aware of the importance of preventative health in protecting against illness & disease.

HEALTHCARE ANALYTICS

Cascade Health Announces Venture Funding Round to Build Intelligent Platform for Healthcare Transparency

PRNewswire | May 16, 2023

Cascade Health, an intelligent platform for healthcare transparency, announced it has raised $1.7 million in venture funding led by AlleyCorp with participation from other strategic angel investors. The company also announced the launch of its first two products: a generative AI assistant to personalize the consumer experience with full visibility around cost and quality of care, as well as APIs that allow companies in the healthcare industry to access data on demand and use it to build their own internal and external products. As healthcare costs have continued to rise in the US, the system has also grown more complex and increasingly opaque. In an effort to counter this, the US government has recently mandated that hospitals and insurance companies publicly disclose pricing data for procedures across the country. Both parties have done so, but in massive files that can't be opened or used without substantial computing power. Cascade Health leverages cloud and AI to aggregate these datasets, along with other public and private healthcare data, to help employers, consumers, government agencies, hospitals, insurance companies and other healthcare-related businesses better understand pricing and coverage. It is the only company that can transform these datasets along with client-specific data and use large language models to interact with the combined data to optimize decision-making in real-time to personalize the experience for anyone seeking or giving care. "We want Cascade Health to become the infrastructure for healthcare transparency – an objective, neutral source for healthcare pricing and coverage," said Ana-Maria Constantin, Cascade Health's CEO and co-founder. "Our intelligent platform provides a window into all this that allows anyone on any side of the healthcare system to make data-driven decisions about the care they receive or deliver." The core of Cascade Health's intelligent platform is a proprietary massive-scale cloud computing infrastructure which works alongside machine learning models and AI to help find, sort and transform massive amounts of healthcare data needed to provide transparency into healthcare pricing and coverage. Cascade Health's generative AI assistant lets consumers ask about coverage options, pricing for different procedures and regions, and more, then uses Cascade Health's platform to deliver data-driven answers to those questions in plain English. The company also provides data management and warehousing infrastructure so customers can benefit from using it without having to worry about storing data. Before founding Cascade Health, Constantin and co-founder Pulak Goyal spent six years at Microsoft building large-scale cloud systems that used machine learning to make intelligent, data-driven decisions for efficient resource utilization. "Complexity and opacity are both endemic in the American healthcare system. It's nearly impossible for stakeholders to make truly informed decisions, whether it's about individual or group coverage, or how to most efficiently deliver and pay for care," said Jane Suh, Principal at AlleyCorp. "We invested in Cascade Health because the team's background and knowledge base perfectly aligns with their mission to bring clarity and access to an essential part of healthcare decision-making." About Cascade Health Cascade Health is an intelligent platform for healthcare transparency. Its intelligent platform is the first to deliver specific data-driven insights that allow consumers, employers buying group insurance plans, government agencies, hospitals, insurance companies to make informed strategic decisions, creating a more affordable and equitable healthcare system for all. Cascade Health is based in Seattle and backed by AlleyCorp and other strategic angels.